Moreover, immunohistochemical identification of glioblastoma cell VEGFR-2 positivity is technically demanding and time-consuming, not least because the fraction of VEGFR-2-positive cells within a given tumor is comparatively low. The gene discussed is KDR; the disease is neoplasm.